Abstract: An implantable drug delivery system includes a middle ear section with a proximal end fixed to a tympanic membrane of a patient, and a distal end that penetrates through a fluid-tight sealed opening into the inner ear. An inner ear section has a proximal end that is connected to the distal end of the middle ear guide member at the sealed opening, and a closed distal end terminating the inner ear holding member some predetermined distance within the cochlea. A hollow interior of the inner ear section is configured for containing a replaceable pharmaceutical agent, and an outer surface is configured to release the pharmaceutical agent from the hollow interior into the inner ear of the patient. The middle ear section and the inner ear section are configured to cooperate for replacing the pharmaceutical agent through the proximal end of the middle ear section to the inner ear section.

Abstract: An implantable drug delivery system includes a middle ear section with a proximal end fixed to a tympanic membrane of a patient, and a distal end that penetrates through a fluid-tight sealed opening into the inner ear. An inner ear section has a proximal end that is connected to the distal end of the middle ear guide member at the sealed opening, and a closed distal end terminating the inner ear holding member some predetermined distance within the cochlea. A hollow interior of the inner ear section is configured for containing a replaceable pharmaceutical agent, and an outer surface is configured to release the pharmaceutical agent from the hollow interior into the inner ear of the patient. The middle ear section and the inner ear section are configured to cooperate for replacing the pharmaceutical agent through the proximal end of the middle ear section to the inner ear section.

Abstract: An implantable fluid delivery system for use in hearing systems includes an implantable fluid pump having a fluid chamber having at least one wall with a membrane, an inlet and an outlet in fluid communication with the fluid chamber, and a floating mass transducer coupled to the membrane. The membrane is configured to move in a first direction increasing a volume of the fluid chamber and to move in a second direction decreasing the volume of the fluid chamber, and the floating mass transducer is configured to cause the membrane to move in the first and second directions. The system further includes an implantable hearing device having one or more fluid channels in fluid communication with the fluid pump.

Abstract: An implantable electrode arrangement for a cochlear implant system is described that prevents post-surgical retraction of the electrode. The arrangement includes at least one retraction limiter having an extracochlear portion located at a distal end of the extracochlear electrode lead and an intracochlear portion located at a proximal end of the intracochlear electrode array and made at least in part of a swellable material that expands in response to fluid contact. The intracochlear portion of the retraction limiter is adapted for deformation away from an outer surface of the array proximal end in response to exposure of the swellable material to perilymph fluid within the cochlea after surgical insertion of the electrode array into the implanted cochlea so as to form an anti-retraction projection preventing post-surgical retraction of the array proximal end back through the electrode opening in the outer surface of the implanted cochlea.

Abstract: An implantable electrode arrangement for a cochlear implant system is described that prevents post-surgical retraction of the electrode. The arrangement includes at least one retraction limiter having an extracochlear portion located at a distal end of the extracochlear electrode lead and an intracochlear portion located at a proximal end of the intracochlear electrode array and made at least in part of a swellable material that expands in response to fluid contact. The intracochlear portion of the retraction limiter is adapted for deformation away from an outer surface of the array proximal end in response to exposure of the swellable material to perilymph fluid within the cochlea after surgical insertion of the electrode array into the implanted cochlea so as to form an anti-retraction projection preventing post-surgical retraction of the array proximal end back through the electrode opening in the outer surface of the implanted cochlea.

Abstract: A system and method for selecting an appropriate implantable hearing device for a patient with a hearing impairment is disclosed. The system includes an auditory parameter generating module configured to receive electronically generated image data of the patient's auditory structure and to generate at least one auditory parameter based on the image data. The system further includes memory, in communication with the auditory parameter generating module, that is configured to store a listing of one or more implantable hearing devices, and a hearing device determining module, in communication with the auditory parameter generating module and the memory, that is configured to select the implantable hearing device based on the auditory parameter.

Abstract: A vestibular implant fitting system is described for fitting a vestibular implant to an implanted patient. An event processing module is configured for monitoring extra-clinical operation of the vestibular implant and collecting extra-clinical implant operation information. A signal processing fitting module is configured for determining a body response characteristic of the implanted patient to a vestibular implant stimulus signal during a response measurement period, and setting an operating characteristic of the vestibular implant based on the body response characteristic and the extra-clinical implant operation information.

Abstract: A system and method for selecting an appropriate implantable hearing device for a patient with a hearing impairment is disclosed. The system includes an auditory parameter generating module configured to receive electronically generated image data of the patient's auditory structure and to generate at least one auditory parameter based on the image data. The system further includes memory, in communication with the auditory parameter generating module, that is configured to store a listing of one or more implantable hearing devices, and a hearing device determining module, in communication with the auditory parameter generating module and the memory, that is configured to select the implantable hearing device based on the auditory parameter.

Abstract: A novel vestibular implant system is described. An implantable vestibular stimulator provides vestibular stimulation signals to stimulate target neural tissue for vestibular sensation by a patient. One or more motion sensors are controllably powered by the vestibular implant system and develop a motion signal reflecting head motion of an implant patient. The vestibular stimulator includes at least two different operating modes: i. a sensor controlled mode wherein the motion sensor is powered and the vestibular stimulation signal is developed as a dependent function of the motion signal, and ii. a sensor independent mode wherein the motion sensor is unpowered and the vestibular stimulation signals, if any, are developed independently of the motion signal.

Abstract: A cochlear implant electrode includes an implantable electrode carrier having an outer surface with electrode contacts for electrically stimulating nerve tissue of the inner ear of a patient. A drug lumen is within the electrode carrier and adapted to receive a therapeutic fluid. The drug lumen contains delivery openings to the outer surface of the electrode carrier and a hydrogel matrix disposed between the drug lumen and the one or more delivery openings and adapted to swell in volume when exposed to the therapeutic fluid. The hydrogel matrix is adapted to control diffusion of the therapeutic fluid from the drug lumen through the delivery openings to the outer surface of the electrode carrier.

Abstract: A device for measuring stapedius tissue activity uses a mechanoelectrical transducer having two ends. A static end is configured for attachment to the bony pyramid in the middle ear, and a dynamic end is configured for attachment to stapedius tissue in the middle ear. The transducer generates a corresponding electrical sensing signal output when the stapedius tissue moves the dynamic end relative to the static end.

Abstract: An implantable fluid delivery system for use in hearing systems includes an implantable fluid pump having a fluid chamber having at least one wall with a membrane, an inlet and an outlet in fluid communication with the fluid chamber, and a floating mass transducer coupled to the membrane. The membrane is configured to move in a first direction increasing a volume of the fluid chamber and to move in a second direction decreasing the volume of the fluid chamber, and the floating mass transducer is configured to cause the membrane to move in the first and second directions. The system further includes an implantable hearing device having one or more fluid channels in fluid communication with the fluid pump.

Abstract: An implantable drug delivery accessory is described. A middle ear guide member has a hollow interior enclosed by a non-permeable outer surface. A proximal end of the middle ear guide member is fixed to the tympanic membrane of an implanted patient. A distal end of the middle ear guide member penetrates through a fluid-tight sealed opening into the inner ear. An inner ear holding member has a proximal end connected to the distal end of the middle ear guide member at the sealed opening and a closed distal end terminating the inner ear holding member some predetermined distance within the cochlea. A hollow interior of the inner ear holding member contains a replaceable drug delivery member which stores a therapeutic drug. A semi-permeable outer surface of the inner ear holding member is connected to a cochlear implant electrode and adapted to release therapeutic drug from the hollow interior into adjacent tissue.

Abstract: A vestibular implant system is described which includes an implantable vestibular stimulator providing a vestibular stimulation signal to electrically stimulate target neural tissue for vestibular sensation by a patient. A patient warning alarm process alters the stimulation signal when a given alarm condition occurs to change the vestibular sensation of the patient thereby warning the patient of the alarm condition.

Abstract: A vestibular implant fitting system and method are described for fitting a vestibular implant to the implanted patient. A body response characteristic of the patient to a vestibular implant stimulus signal is determined during a response measurement period. Then an operating characteristic of the vestibular implant system is set based on the body response characteristic.

Abstract: An implantable device is described based on an implant having a textured outer surface of polymer material with limited transparency. A smooth outer polymer coating covers and cross-links with the textured outer surface to form a coated implant of greater transparency than the polymer material of the implant.

Abstract: A cochlear implant electrode includes an implantable electrode carrier having an outer surface with electrode contacts for electrically stimulating nerve tissue of the inner ear of a patient. A drug lumen is within the electrode carrier and adapted to receive a therapeutic fluid. The drug lumen contains delivery openings to the outer surface of the electrode carrier and a hydrogel matrix disposed between the drug lumen and the one or more delivery openings and adapted to swell in volume when exposed to the therapeutic fluid. The hydrogel matrix is adapted to control diffusion of the therapeutic fluid from the drug lumen through the delivery openings to the outer surface of the electrode carrier.

Abstract: Implantable drug delivery apparatuses and methods are described. An input port septum receives a therapeutic drug. An implantable delivery catheter holds a volume of the therapeutic drug and includes a proximal end in fluid communication with the input port septum, a distal end including an output septum for removing fluid from the catheter, and a drug permeable surface for diffusion of the therapeutic drug into nearby tissue.